Skip to main content
Top
Published in: BMC Public Health 1/2010

Open Access 01-12-2010 | Debate

Re-thinking global health sector efforts for HIV and tuberculosis epidemic control: promoting integration of programme activities within a strengthened health system

Author: Dermot Maher

Published in: BMC Public Health | Issue 1/2010

Login to get access

Abstract

Background

The global financial crisis threatens global health, particularly exacerbating diseases of inequality, e.g. HIV/AIDS, and diseases of poverty, e.g. tuberculosis. The aim of this paper is to reconsider established practices and policies for HIV and tuberculosis epidemic control, aiming at delivering better results and value for money. This may be achieved by promoting greater integration of HIV and tuberculosis control programme activities within a strengthened health system.

Discussion

HIV and tuberculosis share many similarities in terms of their disease burden and the recommended stratagems for their control. HIV and tuberculosis programmes implement similar sorts of control activities, e.g. case finding and treatment, which depend for success on generic health system issues, including vital registration, drug procurement and supply, laboratory network, human resources, and financing. However, the current health system approach to HIV and tuberculosis control often involves separate specialised services. Despite some recent progress, collaboration between the programmes remains inadequate, progress in obtaining synergies has been slow, and results remain far below those needed to achieve universal access to key interventions. A fundamental re-think of the current strategic approach involves promoting integrated delivery of HIV and tuberculosis programme activities as part of strengthened general health services: epidemiological surveillance, programme monitoring and evaluation, community awareness of health-seeking behavior, risk behaviour modification, infection control, treatment scale-up (first-line treatment regimens), drug-resistance surveillance, containing and countering drug-resistance (second-line treatment regimens), research and development, global advocacy and global partnership. Health agencies should review policies and progress in HIV and tuberculosis epidemic control, learn mutual lessons for policy development and scaling up interventions, and identify ways of joint planning and joint funding of integrated delivery as part of strengthened health systems.

Summary

As both a danger and an opportunity, the global financial crisis may entail disaster or recovery for global health sector efforts for HIV and tuberculosis epidemic control. Review of policies and progress in control paves the way for identification of synergies between the two programmes, within strengthened health services. The silver lining in the global economic crisis could be better control of the HIV and tuberculosis epidemics, better overall health system performance and outcomes, and better value for money.
Literature
1.
go back to reference Lopez AD, Mathews CD, Ezzati M, Jamison DT, Murray CL: Global burden of disease and risk factors. 2006, New York: Oxford University Press, Washington, DC: World BankCrossRef Lopez AD, Mathews CD, Ezzati M, Jamison DT, Murray CL: Global burden of disease and risk factors. 2006, New York: Oxford University Press, Washington, DC: World BankCrossRef
2.
go back to reference Maher D, Harries A, Getahun H: Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies. Tropical Medicine and International Health. 2005, 10 (8): 734-42. 10.1111/j.1365-3156.2005.01456.x.CrossRefPubMed Maher D, Harries A, Getahun H: Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies. Tropical Medicine and International Health. 2005, 10 (8): 734-42. 10.1111/j.1365-3156.2005.01456.x.CrossRefPubMed
3.
go back to reference Hahn BH, Shaw GM, De Cock KM, Sharp PM: AIDS as a zoonosis: scientific and public health implications. Science. 2000, 287: 607-14. 10.1126/science.287.5453.607.CrossRefPubMed Hahn BH, Shaw GM, De Cock KM, Sharp PM: AIDS as a zoonosis: scientific and public health implications. Science. 2000, 287: 607-14. 10.1126/science.287.5453.607.CrossRefPubMed
4.
go back to reference Joint United Nations Programme on HIV/AIDS: 2008 Report on the global AIDS epidemic. Geneva. 2008 Joint United Nations Programme on HIV/AIDS: 2008 Report on the global AIDS epidemic. Geneva. 2008
5.
go back to reference Gutierrez MC, Brisse S, Brosch R, Fabre M, Omaïs B, Marmiesse M, Supply P, Vincent V: PLoS Pathogens. 2005, 1 (1): 1-7. 10.1371/journal.ppat.0010005. e5CrossRef Gutierrez MC, Brisse S, Brosch R, Fabre M, Omaïs B, Marmiesse M, Supply P, Vincent V: PLoS Pathogens. 2005, 1 (1): 1-7. 10.1371/journal.ppat.0010005. e5CrossRef
6.
go back to reference Sutherland I: Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Advances in Tuberculosis Research. 1976, 19: 1-63.PubMed Sutherland I: Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Advances in Tuberculosis Research. 1976, 19: 1-63.PubMed
7.
go back to reference National Tuberculosis Institute Bangalore: Tuberculosis in a rural population of South India: a five-year epidemiological study. Bulletin of the World Health Organization. 1974, 51: 473-88. National Tuberculosis Institute Bangalore: Tuberculosis in a rural population of South India: a five-year epidemiological study. Bulletin of the World Health Organization. 1974, 51: 473-88.
8.
go back to reference Dye C, Scheele S, Dolin P, Pathania V, Raviglione M, WHO Global Surveillance and Monitoring Project: Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. Journal of the American Medical Association. 1999, 282: 677-86. 10.1001/jama.282.7.677.CrossRefPubMed Dye C, Scheele S, Dolin P, Pathania V, Raviglione M, WHO Global Surveillance and Monitoring Project: Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. Journal of the American Medical Association. 1999, 282: 677-86. 10.1001/jama.282.7.677.CrossRefPubMed
9.
go back to reference Morgan D, Mahe C, Mayanja B, Whitworth JA: Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. British Medical Journal. 2002, 324: 193-6. 10.1136/bmj.324.7331.193.CrossRefPubMedPubMedCentral Morgan D, Mahe C, Mayanja B, Whitworth JA: Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. British Medical Journal. 2002, 324: 193-6. 10.1136/bmj.324.7331.193.CrossRefPubMedPubMedCentral
10.
go back to reference Comstock GW, Cauthen GM: Epidemiology of tuberculosis. Tuberculosis A Comprehensive International Approach. Edited by: Reichman LB, Hershfield ES. 1993, New York: Marcel Dekker Inc, 66: 23-48. Comstock GW, Cauthen GM: Epidemiology of tuberculosis. Tuberculosis A Comprehensive International Approach. Edited by: Reichman LB, Hershfield ES. 1993, New York: Marcel Dekker Inc, 66: 23-48.
11.
go back to reference Lawn SD, Harries AD, Anglaret X, Myer L, Wood R: Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008, 22: 1897-1908. 10.1097/QAD.0b013e32830007cd.CrossRefPubMed Lawn SD, Harries AD, Anglaret X, Myer L, Wood R: Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008, 22: 1897-1908. 10.1097/QAD.0b013e32830007cd.CrossRefPubMed
12.
go back to reference Borgdorff MW, Floyd K, Broekmans JF: Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bulletin WHO. 2002, 80: 217-227. Borgdorff MW, Floyd K, Broekmans JF: Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bulletin WHO. 2002, 80: 217-227.
13.
go back to reference World Health Organization: Global tuberculosis control: epidemiology, strategy, financing. WHO Report 2009. Geneva. 2009 World Health Organization: Global tuberculosis control: epidemiology, strategy, financing. WHO Report 2009. Geneva. 2009
14.
go back to reference Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Corbett EL, Dye C: The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine. 2003, 163: 1009-21. 10.1001/archinte.163.9.1009.CrossRefPubMed Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Corbett EL, Dye C: The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine. 2003, 163: 1009-21. 10.1001/archinte.163.9.1009.CrossRefPubMed
15.
go back to reference Dye C, Harries A, Maher D, Hosseini S, Nkhoma W, Salaniponi F: Tuberculosis. Disease Morbidity and Mortality in sub-Saharan Africa. Edited by: Feachem R. 2006, Washington DC: World Bank Dye C, Harries A, Maher D, Hosseini S, Nkhoma W, Salaniponi F: Tuberculosis. Disease Morbidity and Mortality in sub-Saharan Africa. Edited by: Feachem R. 2006, Washington DC: World Bank
16.
go back to reference World Health Organization: A strategic framework to decrease the burden of TB/HIV (WHO/CDS/TB/2002.296). Geneva. 2002 World Health Organization: A strategic framework to decrease the burden of TB/HIV (WHO/CDS/TB/2002.296). Geneva. 2002
17.
go back to reference World Health Organization: An analysis of interaction between tuberculosis and HIV/AIDS programmes in sub-Saharan Africa. (WHO/CDS/TB/2001.294). Geneva. 2001 World Health Organization: An analysis of interaction between tuberculosis and HIV/AIDS programmes in sub-Saharan Africa. (WHO/CDS/TB/2001.294). Geneva. 2001
18.
go back to reference Merson MH, O'Malley J, Serwadda D, Apisuk C: The history and challenge of HIV prevention. Lancet. 2008, 372: 475-88. 10.1016/S0140-6736(08)60884-3.CrossRefPubMed Merson MH, O'Malley J, Serwadda D, Apisuk C: The history and challenge of HIV prevention. Lancet. 2008, 372: 475-88. 10.1016/S0140-6736(08)60884-3.CrossRefPubMed
19.
go back to reference Padian NS, Buvé A, Balkus J, Serwadda D, Cates W: Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet. 2008, 372: 585-599. 10.1016/S0140-6736(08)60885-5.CrossRefPubMed Padian NS, Buvé A, Balkus J, Serwadda D, Cates W: Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet. 2008, 372: 585-599. 10.1016/S0140-6736(08)60885-5.CrossRefPubMed
20.
go back to reference De Cock KM, Gilks CF, Lo YR, Guerma T: Can antiretroviral therapy eliminate HIV transmission?. Lancet. 2008, DOI:10.1016/S0140-6736(08)61732-8 De Cock KM, Gilks CF, Lo YR, Guerma T: Can antiretroviral therapy eliminate HIV transmission?. Lancet. 2008, DOI:10.1016/S0140-6736(08)61732-8
21.
go back to reference Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG: Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2008, 373: 48-57. 10.1016/S0140-6736(08)61697-9.CrossRefPubMed Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG: Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2008, 373: 48-57. 10.1016/S0140-6736(08)61697-9.CrossRefPubMed
22.
go back to reference Maher D, Espinal M, Raviglione M: Tuberculosis. Oxford Textbook of Public Health. Edited by: Detels et al. 2009, Oxford: Oxford University Press, Fifth Maher D, Espinal M, Raviglione M: Tuberculosis. Oxford Textbook of Public Health. Edited by: Detels et al. 2009, Oxford: Oxford University Press, Fifth
23.
go back to reference Maher D, Raviglione M: The history of the DOTS strategy: achievements and perspectives. Tuberculosis. Edited by: Schaaf S, Zumla A. 2009, London: Elsevier Maher D, Raviglione M: The history of the DOTS strategy: achievements and perspectives. Tuberculosis. Edited by: Schaaf S, Zumla A. 2009, London: Elsevier
24.
go back to reference Rouillon A, Perdrizet S, Parrot R: Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle. 1976, 57: 275-299. 10.1016/S0041-3879(76)80006-2.CrossRefPubMed Rouillon A, Perdrizet S, Parrot R: Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle. 1976, 57: 275-299. 10.1016/S0041-3879(76)80006-2.CrossRefPubMed
25.
go back to reference Coates TJ, Richter L, Caceres C: Behavioural strategies to reduce HIV transmission: how to make them better. Lancet. 2008, 372: 669-84. 10.1016/S0140-6736(08)60886-7.CrossRefPubMedPubMedCentral Coates TJ, Richter L, Caceres C: Behavioural strategies to reduce HIV transmission: how to make them better. Lancet. 2008, 372: 669-84. 10.1016/S0140-6736(08)60886-7.CrossRefPubMedPubMedCentral
26.
go back to reference Wodak A: The role of harm reduction in controlling HIV among injecting drug users. AIDS. 2008, 22 (Suppl 2): S81-92. 10.1097/01.aids.0000327439.20914.33.CrossRefPubMedPubMedCentral Wodak A: The role of harm reduction in controlling HIV among injecting drug users. AIDS. 2008, 22 (Suppl 2): S81-92. 10.1097/01.aids.0000327439.20914.33.CrossRefPubMedPubMedCentral
27.
go back to reference World Health Organization: WHO policy on TB infection control in health-care facilities, congregate settings and households. WHO/HTM/TB/2009.419 Geneva. 2009 World Health Organization: WHO policy on TB infection control in health-care facilities, congregate settings and households. WHO/HTM/TB/2009.419 Geneva. 2009
28.
go back to reference World Health Organization: Guidelines for the prevention of tuberculosis in health care facilities in resource-limited settings. Geneva. 1999 World Health Organization: Guidelines for the prevention of tuberculosis in health care facilities in resource-limited settings. Geneva. 1999
30.
go back to reference World Health Organization: SEX-RAR Guide. The rapid assessment and response guide on psychoactive substance use and sexual risk behaviour. Geneva. 2002 World Health Organization: SEX-RAR Guide. The rapid assessment and response guide on psychoactive substance use and sexual risk behaviour. Geneva. 2002
31.
go back to reference Mellenekamp MA, Jerrells TR: Effects of ethanol consumption on susceptibility to pulmonary and gastrointestinal infections. Alcohol Clin Exp Res. 1996, 20 (suppl): 192A-5A. 10.1111/j.1530-0277.1996.tb01774.x.CrossRef Mellenekamp MA, Jerrells TR: Effects of ethanol consumption on susceptibility to pulmonary and gastrointestinal infections. Alcohol Clin Exp Res. 1996, 20 (suppl): 192A-5A. 10.1111/j.1530-0277.1996.tb01774.x.CrossRef
32.
go back to reference Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR: Risk of tuberculosis from exposure to tobacco smoke. A systematic review and meta-analysis. Arch Intern Med. 2007, 167: 335-342. 10.1001/archinte.167.4.335.CrossRefPubMed Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR: Risk of tuberculosis from exposure to tobacco smoke. A systematic review and meta-analysis. Arch Intern Med. 2007, 167: 335-342. 10.1001/archinte.167.4.335.CrossRefPubMed
33.
go back to reference Korenromp EL, White RG, Orroth KK, Bakker R, Kamali A, Serwadda D, Gray RH, Grosskurth H, Habbema JD, Hayes RJ: Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai and Masaka intervention trials. J Infect Dis. 2005, 191 (suppl 1): S168-78. 10.1086/425274.CrossRefPubMed Korenromp EL, White RG, Orroth KK, Bakker R, Kamali A, Serwadda D, Gray RH, Grosskurth H, Habbema JD, Hayes RJ: Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai and Masaka intervention trials. J Infect Dis. 2005, 191 (suppl 1): S168-78. 10.1086/425274.CrossRefPubMed
34.
go back to reference Harries AD, Billo N, Kapur A: Links between diabetes mellitus and tuberculosis: should we integrate screening and care?. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009, 103: 1-2. 10.1016/j.trstmh.2008.08.008.CrossRefPubMed Harries AD, Billo N, Kapur A: Links between diabetes mellitus and tuberculosis: should we integrate screening and care?. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009, 103: 1-2. 10.1016/j.trstmh.2008.08.008.CrossRefPubMed
35.
go back to reference Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, de Zoysa I, Dye C, Auvert B: The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med. 2006, 3: e262-10.1371/journal.pmed.0030262.CrossRefPubMedPubMedCentral Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, de Zoysa I, Dye C, Auvert B: The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med. 2006, 3: e262-10.1371/journal.pmed.0030262.CrossRefPubMedPubMedCentral
36.
go back to reference Liu AY, Grant RM, Buchbinder SP: Preexposure prophylaxis for HIV: unproven promise and potential pitfalls. JAMA. 2006, 296: 863-65. 10.1001/jama.296.7.863.CrossRefPubMed Liu AY, Grant RM, Buchbinder SP: Preexposure prophylaxis for HIV: unproven promise and potential pitfalls. JAMA. 2006, 296: 863-65. 10.1001/jama.296.7.863.CrossRefPubMed
37.
go back to reference World Health Organization: Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva. 2006 World Health Organization: Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva. 2006
38.
go back to reference World Health Organization: Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access; recommendations for a public health approach. Geneva. 2006 World Health Organization: Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access; recommendations for a public health approach. Geneva. 2006
39.
go back to reference Fisher M, Benn P, Evans B, Pozniak A, Jones M, MacLean S, Davidson O, Summerside J, Hawkins DC, Clinical Effectiveness Group (British Association for Sexual Health and HIV): UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure. Int J STD AIDS. 2006, 17: 81-92. 10.1258/095646206775455829.CrossRefPubMed Fisher M, Benn P, Evans B, Pozniak A, Jones M, MacLean S, Davidson O, Summerside J, Hawkins DC, Clinical Effectiveness Group (British Association for Sexual Health and HIV): UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure. Int J STD AIDS. 2006, 17: 81-92. 10.1258/095646206775455829.CrossRefPubMed
40.
go back to reference World Health Organization: Preventive Therapy against Tuberculosis in People Living with HIV. Weekly Epidemiological Record. 1999, 74: 385-98. World Health Organization: Preventive Therapy against Tuberculosis in People Living with HIV. Weekly Epidemiological Record. 1999, 74: 385-98.
41.
go back to reference Velasco-Hernandez JX, Gershengorn HB, Blower SM: Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?. Lancet Infect Dis. 2002, 2: 487-93. 10.1016/S1473-3099(02)00346-8.CrossRefPubMed Velasco-Hernandez JX, Gershengorn HB, Blower SM: Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?. Lancet Infect Dis. 2002, 2: 487-93. 10.1016/S1473-3099(02)00346-8.CrossRefPubMed
42.
go back to reference Montaner JS, Hogg R, Wood E, Kerr T, Tyndall M, Levy AR, Harrigan PR: The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006, 368: 531-36. 10.1016/S0140-6736(06)69162-9.CrossRefPubMed Montaner JS, Hogg R, Wood E, Kerr T, Tyndall M, Levy AR, Harrigan PR: The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006, 368: 531-36. 10.1016/S0140-6736(06)69162-9.CrossRefPubMed
43.
go back to reference Garnett GP, Baggaley RF: Treating our way out of the HIV pandemic: could we, would we, should we?. Lancet. 2008, DOI:10.1016/S0140-6736(08)61698-0 Garnett GP, Baggaley RF: Treating our way out of the HIV pandemic: could we, would we, should we?. Lancet. 2008, DOI:10.1016/S0140-6736(08)61698-0
44.
go back to reference Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC: International Standards for Tuberculosis Care. Lancet Infectious Diseases. 2006, 6: 710-25. 10.1016/S1473-3099(06)70628-4.CrossRefPubMed Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC: International Standards for Tuberculosis Care. Lancet Infectious Diseases. 2006, 6: 710-25. 10.1016/S1473-3099(06)70628-4.CrossRefPubMed
45.
go back to reference Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg H, Mosteller F: Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. Journal of the American Medical Association. 1994, 271: 698-702. 10.1001/jama.271.9.698.CrossRefPubMed Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg H, Mosteller F: Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. Journal of the American Medical Association. 1994, 271: 698-702. 10.1001/jama.271.9.698.CrossRefPubMed
46.
go back to reference World Health Organization: Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009. Geneva. 2000 World Health Organization: Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009. Geneva. 2000
47.
go back to reference Rosen S, Fox M, Gill C: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review PLoS Medicine. 2007, 10: e29- Rosen S, Fox M, Gill C: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review PLoS Medicine. 2007, 10: e29-
48.
go back to reference Bennett DE, Bertagnolio S, Sutherland D, Gilks CF: The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antiviral Therapy. 2008, 13 (suppl 2): 1-13.PubMed Bennett DE, Bertagnolio S, Sutherland D, Gilks CF: The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antiviral Therapy. 2008, 13 (suppl 2): 1-13.PubMed
49.
go back to reference Wright A, Zignol M, Van Deun A, Falzon D, Ruesch Gerdes S, Feldmann K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, Boulabhal F, Paramasivan CN, Kam KM, Mitarai S, Nunn P, Raviglione M: Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet. 2009, 373: 1861-73. 10.1016/S0140-6736(09)60331-7.CrossRefPubMed Wright A, Zignol M, Van Deun A, Falzon D, Ruesch Gerdes S, Feldmann K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, Boulabhal F, Paramasivan CN, Kam KM, Mitarai S, Nunn P, Raviglione M: Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet. 2009, 373: 1861-73. 10.1016/S0140-6736(09)60331-7.CrossRefPubMed
50.
go back to reference World Health Organization: Use of antiretroviral therapy in resource-limited countries in 2007: distribution and uptake of first- and second-line regimens. Geneva. 2008 World Health Organization: Use of antiretroviral therapy in resource-limited countries in 2007: distribution and uptake of first- and second-line regimens. Geneva. 2008
51.
go back to reference World Health Organization and Stop TB Partnership: The Global Plan to Stop TB, 2006-2015. Geneva. 2006 World Health Organization and Stop TB Partnership: The Global Plan to Stop TB, 2006-2015. Geneva. 2006
52.
go back to reference World Health Organization: Community contribution to TB care: practice and policy. Review of experience of community contribution to TB care and recommendations to National TB Programmes. Geneva. 2003 World Health Organization: Community contribution to TB care: practice and policy. Review of experience of community contribution to TB care and recommendations to National TB Programmes. Geneva. 2003
53.
go back to reference WHO and Stop TB Partnership: Report on the meeting of the second ad hoc committee on the tuberculosis epidemic, Montreux, Switzerland, 18-19 September 2003. Geneva. 2004 WHO and Stop TB Partnership: Report on the meeting of the second ad hoc committee on the tuberculosis epidemic, Montreux, Switzerland, 18-19 September 2003. Geneva. 2004
54.
go back to reference World Health Organization: A strategic framework to decrease the burden of TB/HIV. Geneva. 2002 World Health Organization: A strategic framework to decrease the burden of TB/HIV. Geneva. 2002
55.
go back to reference World Health Organization: Interim policy on TB/HIV collaborative activities. WHO, Geneva, 2004 (WHO/HTM/TB/2004. 330. WHO/HTM/HIV/2004.1). Geneva. 2004 World Health Organization: Interim policy on TB/HIV collaborative activities. WHO, Geneva, 2004 (WHO/HTM/TB/2004. 330. WHO/HTM/HIV/2004.1). Geneva. 2004
60.
61.
go back to reference Cornetto G, Ooms G, Starrs A, Zeitz P: A global fund for the health MDGs?. Lancet. 2009, 373: 1500-02. 10.1016/S0140-6736(09)60835-7.CrossRef Cornetto G, Ooms G, Starrs A, Zeitz P: A global fund for the health MDGs?. Lancet. 2009, 373: 1500-02. 10.1016/S0140-6736(09)60835-7.CrossRef
62.
go back to reference Horton R: The global financial crisis: an acute threat to health. Lancet. 2009, 373: 355-6. 10.1016/S0140-6736(09)60116-1.CrossRefPubMed Horton R: The global financial crisis: an acute threat to health. Lancet. 2009, 373: 355-6. 10.1016/S0140-6736(09)60116-1.CrossRefPubMed
64.
go back to reference Anonymous: Crunch time for tuberculosis control (Editorial). Lancet. 2009, 373: 1145-10.1016/S0140-6736(09)60662-0.CrossRef Anonymous: Crunch time for tuberculosis control (Editorial). Lancet. 2009, 373: 1145-10.1016/S0140-6736(09)60662-0.CrossRef
65.
go back to reference World Health Organization: An analysis of interaction between TB and HIV/AIDS programmes in sub-Saharan Africa. Geneva. 2002 World Health Organization: An analysis of interaction between TB and HIV/AIDS programmes in sub-Saharan Africa. Geneva. 2002
Metadata
Title
Re-thinking global health sector efforts for HIV and tuberculosis epidemic control: promoting integration of programme activities within a strengthened health system
Author
Dermot Maher
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2010
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-10-394

Other articles of this Issue 1/2010

BMC Public Health 1/2010 Go to the issue